Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate in Primary Biliary Cholangitis
NCT06247735Phase 2Completed
- Start
- Feb 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pemafibrate in primary biliary cholangitis (PBC). Started Feb 2024; status: completed.
02
Drugs
pemafibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT06247735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06247735.